P16INK4a Upregulation Mediated by SIX6 Defines Retinal Ganglion Cell Pathogenesis in Glaucoma

Area of Science:

• Ophthalmology
• Neuroscience
• Genetics

Background:

• Glaucoma is a leading cause of irreversible blindness.
• Retinal ganglion cell (RGC) death characterizes glaucoma, a neurodegenerative disease.
• The precise mechanisms driving RGC death in glaucoma remain elusive.

Purpose of the Study:

• To investigate the interplay between the SIX6 gene variant (rs33912345, His141Asn) and p16INK4a in glaucoma pathogenesis.
• To elucidate the molecular mechanisms underlying RGC death in glaucoma.
• To establish a unified theory for glaucoma pathogenesis linking genetic factors and intraocular pressure (IOP).

Main Methods:

• Utilized a mouse model with elevated IOP.
• Analyzed human primary open-angle glaucoma (POAG) eyes.
• Examined the expression of SIX6 and p16INK4a in relation to genetic risk alleles and IOP.

Main Results:

• The SIX6 risk variant (His141Asn) synergizes with p16INK4a, a major POAG risk gene.
• Homozygous SIX6 risk alleles (CC) upregulate p16INK4a expression, inducing cellular senescence.
• Elevated IOP and SIX6 variants promote POAG by increasing p16INK4a, causing RGC senescence in human retinas.

Conclusions:

• SIX6 and IOP directly increase p16INK4a expression, driving RGC senescence.
• This study links genetic susceptibility to the mechanism of RGC death in glaucoma.
• Findings provide a unified theory for glaucoma pathogenesis, integrating genetic and environmental factors.